BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32507487)

  • 1. A Direct Comparison Between Institut Georges Lopez 1 and Histidine-Tryptophan-Ketoglutarate Preservation Solutions in Liver Transplantation.
    Kiyoshi Takano de Saidneuy AE; Bruno de Rezende M; Rogerio de Oliveira Salvalaggio P
    Transplant Proc; 2020 Jun; 52(5):1262-1264. PubMed ID: 32507487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of IGL-1 preservation solution in liver transplantation.
    Wiederkehr JC; Igreja MR; Nogara MS; Goncalves N; Montemezzo GP; Wiederkehr HA; Wassen MP; Nobrega HA; Zenatti KB; Mori LY; Tudisco MS
    Transplant Proc; 2014; 46(6):1809-11. PubMed ID: 25131043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver Transplantation.
    Meine MH; Leipnitz I; Zanotelli ML; Schlindwein ES; Kiss G; Martini J; de Medeiros Fleck A; Mucenic M; de Mello Brandão A; Marroni CA; Craco Cantisani GP
    Transplant Proc; 2015 May; 47(4):888-93. PubMed ID: 26036479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Protection Against Cold Ischemia Preservation: An Institute George Lopez 1 and Histidine-tryptophan-ketoglutarate Solution Appraisal.
    Panisello-Rosello A; Castro-Benítez C; Lopez A; Balloji S; Folch-Puy E; Adam R; Roselló-Catafau J
    Transplant Proc; 2018 Apr; 50(3):714-718. PubMed ID: 29661422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK.
    Panisello-Roselló A; Verde E; Lopez A; Flores M; Folch-Puy E; Rolo A; Palmeira C; Hotter G; Carbonell T; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relevance of the UPS in Fatty Liver Graft Preservation: A New Approach for IGL-1 and HTK Solutions.
    Panisello-Roselló A; Verde E; Amine Zaouali M; Flores M; Alva N; Lopez A; Folch-Puy E; Carbonell T; Hotter G; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis.
    Szilágyi ÁL; Mátrai P; Hegyi P; Tuboly E; Pécz D; Garami A; Solymár M; Pétervári E; Balaskó M; Veres G; Czopf L; Wobbe B; Szabó D; Wagner J; Hartmann P
    World J Gastroenterol; 2018 Apr; 24(16):1812-1824. PubMed ID: 29713134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Flush With Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solutions in Liver Transplantation: Preliminary Results.
    León Díaz FJ; Fernández Aguilar JL; Nicolás de Cabo S; Pérez Reyes M; Sánchez Pérez B; Montiel Casado C; Pérez Daga JA; Aranda Narváez JM; Suárez Muñoz MA; Arenas González F; Florez Rías MM; Pelaez Angulo JL; Santoyo Santoyo J
    Transplant Proc; 2018 Mar; 50(2):539-542. PubMed ID: 29579846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.
    Adam R; Delvart V; Karam V; Ducerf C; Navarro F; Letoublon C; Belghiti J; Pezet D; Castaing D; Le Treut YP; Gugenheim J; Bachellier P; Pirenne J; Muiesan P;
    Am J Transplant; 2015 Feb; 15(2):395-406. PubMed ID: 25612492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Institut Georges Lopez-1 and Celsior preservation solutions on liver graft injury.
    Tabka D; Bejaoui M; Javellaud J; Roselló-Catafau J; Achard JM; Abdennebi HB
    World J Gastroenterol; 2015 Apr; 21(14):4159-68. PubMed ID: 25892865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of canine liver grafts using HTK solution.
    van Gulik TM; Reinders ME; Nio R; Frederiks WM; Bosma A; Klopper PJ
    Transplantation; 1994 Jan; 57(2):167-71. PubMed ID: 8310502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcomes using two preservation solutions (UW/HTK) in liver transplantation from brain death donors].
    Martínez J; Bächler JP; Moisan F; Torres J; Duarte I; Pérez RM; Benítez C; Arrese M; Domínguez P; Guerra JF; Jarufe N
    Rev Med Chil; 2014 Oct; 142(10):1229-37. PubMed ID: 25601106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation.
    Rayya F; Harms J; Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):891-4. PubMed ID: 18555073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycocalyx Preservation and NO Production in Fatty Livers-The Protective Role of High Molecular Polyethylene Glycol in Cold Ischemia Injury.
    Lopez A; Panisello-Rosello A; Castro-Benitez C; Adam R
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors.
    Mangus RS; Fridell JA; Vianna RM; Milgrom MA; Chestovich P; Chihara RK; Tector AJ
    Liver Transpl; 2008 Mar; 14(3):365-73. PubMed ID: 18306380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study.
    Testa G; Malagó M; Nadalin S; Treptow B; Paul A; Frilling A; Broelsch CE
    Liver Transpl; 2003 Aug; 9(8):822-6. PubMed ID: 12884194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of perfusate on liver viability during hypothermic machine perfusion.
    Jia JJ; Zhang J; Li JH; Chen XD; Jiang L; Zhou YF; He N; Xie HY; Zhou L; Zheng SS
    World J Gastroenterol; 2015 Aug; 21(29):8848-57. PubMed ID: 26269674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation.
    Nardo B; Bertelli R; Montalti R; Beltempo P; Puviani L; Pacilè V; Cavallari A
    Transplant Proc; 2005; 37(1):320-2. PubMed ID: 15808630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation.
    Liu Q; Bruns H; Schultze D; Xue Y; Zorn M; Flechtenmacher C; Straub BK; Rauen U; Schemmer P
    Langenbecks Arch Surg; 2012 Dec; 397(8):1323-31. PubMed ID: 23111581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation.
    Hatano E; Kiuchi T; Tanaka A; Shinohara H; Kitai T; Satoh S; Inomoto T; Egawa H; Uemoto S; Inomata Y; Lang H; Oldhafer KJ; Ringe B; Pichlmayr R; Tanaka K; Yamaoka Y
    Clin Sci (Lond); 1997 Jul; 93(1):81-8. PubMed ID: 9279207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.